M. Kulyk & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.34M | Buy |
77,322
+11,425
| +17% | +$789K | 1.16% | 31 |
|
|
2025
Q1 | $4.58M | Buy |
65,897
+62,715
| +1,971% | +$4.35M | 1.05% | 37 |
|
|
2024
Q4 | $274K | Buy |
3,182
+119
| +4% | +$10.2K | 0.06% | 85 |
|
|
2024
Q3 | $365K | Sell |
3,063
-1,573
| -34% | -$187K | 0.07% | 79 |
|
|
2024
Q2 | $662K | Sell |
4,636
-900
| -16% | -$128K | 0.15% | 59 |
|
|
2024
Q1 | $711K | Sell |
5,536
-324
| -6% | -$41.6K | 0.16% | 60 |
|
|
2023
Q4 | $606K | Buy |
+5,860
| New | +$606K | 0.14% | 65 |
|